FDA Determines Regulatory Review Period for MICRA TRANSCATHETER PACING SYSTEM Patent Extension

Summary

The US Food and Drug Administration has published a notice determining the regulatory review period for the extension of a patent for the MICRA TRANSCATHETER PACING SYSTEM, following a submission to the US Patent and Trademark Office.